Amblyopia or lazy eye is weak vision or vision loss in one eye that cannot be fully corrected with lenses. This eye condition can affect up to 5% of the general population. Amblyopia usually develops in children before age eight. This is also the key time to treat it since results are better the earlier they are implemented. It becomes more difficult to treat amblyopia after the early teenage years. Untreated, amblyopia can, in rare cases, lead to blindness in the affected eye.
Amblyopia is a neurodevelopmental disorder that affects at least 2% of most populations and can lead to permanently reduced vision if not detected and treated within a specific period in childhood.
Amblyopia cause, why it happens
This
eye disorder is caused when the brain favors one eye and refuses to use the
other. Simply stated, it is a dysfunction of the brain which blocks
vision from one eye because it can't use the two eyes together. Because the eye
is "turned off, " clear vision does not develop in the lazy eye. Amblyopia
affects 2 to 3 percent of the population.
Natural supplement
Indian J Ophthalmology. 2014.
Effectiveness of the addition of citicoline to patching in the treatment
of amblyopia around visual maturity: a randomized controlled trial. o
study the effectiveness of the addition of citicoline to patching in the
treatment of amblyopia in the age group of 4-13 years. A randomized
controlled trial, which included patients who were randomly divided into
two groups. Both the groups received patching therapy till plateau was
achieved in phase 1 of the study. Then in phase 2, group I received
citicoline plus patching and group II continued to receive only
patching. Outcome was measured by the visual acuity in logMAR every
month in phase 1 till plateau was achieved and then for 12 months in
phase 2. No significant difference was found in the mean visual acuities
in these two groups in phase 1 till plateau was reached. In phase 2, for
the initial four months, there was no significant difference in the
visual acuities in these two groups, at the respective intervals.
However, five months onward, up to 12 months, there was a significant
difference in the visual acuities in these groups. The result was the
same in younger patients (< seven years of age) as well as in older
patients (> seven years of age). In phase 2, the mean proportional
improvement in group I was significantly more than that in group II, at
two months and onward, at the respective intervals. The improvement in
visual acuity with citicoline plus patching was significantly more than
that with patching alone, in one year of treatment.
Amblyopia treatment, how to improve
Although it is widely agreed that this condition that involves poor
vision and/or poor muscle control of one eye, can be effectively treated in
children younger than six, it has generally been believed that older children
were unlikely to benefit from amblyopia treatment. The upper limit for successful
amblyopia treatment response has been believed
to be six to seven or nine to ten years of age. The current study is designed to
evaluate the effectiveness of treatment of amblyopia in children aged seven to
17 years. Researchers conducted a randomized
treatment trial of 507 older children with amblyopia at 49 clinical sites. All
the patients were provided with optimal optical correction (children who already
had glasses were given new ones). Children were then randomly assigned to
receive treatment for amblyopia or to receive optical correction alone. Children
aged seven to 12 in the treatment group were treated with two to six hours a day
of patching over the sound eye combined with near visual activities such as
playing with a GameBoy, homework, or reading, and one drop daily of atropine for
the sound eye. Patients in the older treatment group (aged 13 to 17 years) were
treated with patching and near visual activities alone.
Follow up visits occurred every six weeks for up to 24 weeks until the patients
were classified as a responder or non-responder. A patient in the study was
classified as a responder if the amblyopic eye acuity (sharpness of vision) was
10 or more letters (two lines on the eye chart) better than baseline. A patient
was classified as a non-responder if amblyopic eye acuity had not improved 10 or
more letters by the 24th week or if there was no improvement at all from a prior
follow-up visit (or baseline).
Of the 404 seven- to 12-year-olds in the study, 53 percent in the amblyopia treatment group were responders compared with 25 percent in the optical
correction group. Of the 13- to 17- year-olds, 25 percent of the treatment group
were responders compared with 23 percent of the optical correction
group. However, of the13- to 17- year-olds who had not previously
been treated for amblyopia, 47 percent responded to treatment
compared to 20 percent who did not. Arch Ophthalmology. 2005.
Clin Neuropharmacol. 2016. Levodopa and Other Pharmacologic Interventions in Ischemic and Traumatic Optic Neuropathies and Amblyopia. The visual impairment in traumatic and ischemic optic neuropathy and amblyopia may be permanent. Hence, lots of efforts have been focused on neuroprotection. Dopamine is one of the suggested neuroprotective agents. Besides its important role in the brain, dopamine is found in various cell types of the retina, and is claimed to play a neuromodulator and neurotransmitter role there. The dopamine D1 receptor is the most highly expressed subtype of dopamine receptors, and its activation has been shown to be potentially neuroprotective against oxidative-stress damage in retinal neurons. Levodopa, a precursor of dopamine, can easily breach the blood-brain and blood-retinal barriers, and exerts effective dopaminergic responses in the brain and retina. This article summarizes and discusses the use of levodopa and other pharmacologic agents in the treatment of 3 groups of visual pathway disorders that primarily involve neuronal systems: ischemic optic neuropathy, traumatic optic neuropathy, and amblyopia.
Patching
Br J Ophthalmology. 2010. Effect and sustainability of part-time
occlusion therapy for patients with anisometropic amblyopia aged > or =8
years. Department of Ophthalmology, Hallym University Sacred Heart
Hospital, Republic of Korea.
To study the effect and long-term sustainability of part-time occlusion
therapy for anisometropic amblyopia after 8 years of age. A total of 41
anisometropic amblyopes aged > or =8 years were analysed. In six
patients, best-corrected visual acuity (BCVA) of amblyopic eye improved
more than two lines within 2 weeks of full-time spectacle wear. The
remaining patients were assigned to perform part-time patching during
out-of-school hours. Long-term results were assessed in patients who
were observed over 1 year after the end of the treatment. The part-time
patching schedule was completed in 30 patients. 90% of patients
complied well. Mean BCVA in the amblyopic eye improved significantly.
The part-time occlusion treatment in school-aged amblyopes, which had
been carried out after school hours, was successful and the effect was
sustained in most cases.
Eyesight Rx for better vision day and
evening. Provides reading and distance vision improvement
Vitamin C (Ascorbic acid)
Citrus bioflavonoids (eriocitrin, hesperidin, flavonols, flavones,
flavonoids, naringenin, and quercetin)
Mixed carotenoids (astaxanthin, beta carotene, cryptoxanthin,
lutein,
Lycopene,
Zeaxanthin)
Bilberry
extract (Vaccinium myrtillus)
Jujube extract (Zizyphus jujube)
Ginkgo biloba
pill
Suma extract (Pfaffia paniculata)
Mucuna pruriens extract
Lycium berry extract
Sarsaparila (Sarsaparilla Smilax)
Alpha lipoic acid as
an antioxidant
Laser acupuncture treatment
J Acupunct Meridian Stud. 2016. Amblyopia: Can Laser Acupuncture be an
Option? Vanzini M, Gallamini M. After obtaining satisfactory results in
the treatment of a 14-year-old amblyopic girl, the treatment was applied
to 13 amblyopic children aged 3-11 years, with an encouraging outcome.
An ultralow-light-intensity laser with a square-wave modulated emission
was applied over a sequence of acupuncture points. Each session lasted
less than 15 minutes, and the treatment was performed once a week in
6-week cycles. Patients were followed for several years to evaluate the
long-term results and/or to extend the treatment. All except two of the
treated patients showed a rapid increase in visual acuity after several
treatment sessions. Some required retreatment for regressions in visual
acuity. The need for medium-term treatment cycles seems, however, to
suggest that results may not be stable for all individuals. Although
acupuncture has already been proved to be effective in the treatment of
amblyopia, results suggest that laser acupuncture at
ultra-low-light-intensity levels can provide similar, if not better,
results to conventional acupuncture stimulation, but with higher patient
compliance.
Research study
The prevalence of strabismus and amblyopia in Japanese elementary school
children.
Ophthalmic Epidemiol. 2005.
The purpose of this study is to elucidate the prevalence of
strabismus and amblyopia in a large population of Japanese elementary school
children, from Grade 1 to Grade 6, ages ranging from 6 to 12 years. The School
Health Law requires that all pupils in Grade 1 to Grade 6 be examined for vision
and eye problems. Visual acuity testing is done by school teachers and eye
disease screening by school ophthalmologists. Pupils with suspected ocular
diseases are further examined by extramural ophthalmologists and the results
reported back to the schools. The schools then summarize and send uncorrected
visual acuity and ocular disease incidence, together with other health
statistics, to the municipal education committees. The data are forwarded to the
Prefecture Governments and finally submitted to the Education Ministry of the
Central Government. Both the Prefecture Governments and the Education Ministry
publicize the school health statistics on their websites. The prevalence of
strabismus and amblyopia remains unknown from these data because both diagnoses
are included under the heading, eye diseases. Questionnaires asking
about the numbers of children with different types of strabismus and amblyopia
were sent to all elementary schools in Okayama Prefecture and the results were
summarized. The number of children covered by the return of
questionnaires was 86,531 (76%) of 113,254 total pupils in Grade 1 to Grade 6
in Okayama Prefecture in the year 2003. The total numbers of children with
strabismus and amblyopia were 1,112 (1.28%) and 125, respectively. The
numbers of children with any type of exotropia and any type of esotropia were
602 (0.69%) and 245, respectively. The major types of strabismus and amblyopia were intermittent exotropia in 109 children, accommodative esotropia in 19 children, anisometropic amblyopia in 23 children
(0.03%), and ametropic amblyopia in 12 children (0.01%). The number of children
with strabismus of unknown type was 245 while the number of children
with amblyopia of unknown type was 81. The prevalence rates
of strabismus and amblyopia in this population of Japanese elementary school
children were lower than those reported in Western countries. The exotropia / esotropia
ratio were increased in comparison with past studies in Japan. The school eye
doctors need to be more diligent in identifying and diagnosing various types of
strabismus and amblyopia in order to contribute to the school vision screening
program already in place in Japan.
Amblyopia characterization, treatment, and prophylaxis.
Surv Ophthalmol. 2005. Simons K.
Pediatric Vision Laboratory, Krieger Children's Eye Center, Wilmer Institute,
Johns Hopkins University School of Medicine, Baltimore, Maryland
Amblyopia has a 1.6-3.6% prevalence, higher in the medically underserved. It
is more complex than simply visual acuity loss and the better eye has
sub-clinical deficits. Functional limitations appear more extensive and loss of
vision in the better eye of amblyopes more prevalent than previously thought.
Refractive correction alone may successfully treat anisometropic amblyopia and it, minimal occlusion, and/or catecholamine
treatment can provide initial vision improvement that may improve compliance
with subsequent long-duration treatment. Atropine penalization appears as
effective as occlusion for moderate amblyopia, with limited-day penalization as
effective as full-time. Cytidin-5'-diphosphocholine may hold promise as a
medical treatment. Interpretation of much of the amblyopia literature is made
difficult by: inaccurate visual acuity measurement at initial visit, lack of
adequate refractive correction prior to and during treatment, and lack of
long-term follow-up results. Successful treatment can be achieved in at most
63-83% of patients. Treatment outcome is a function of initial visual acuity and
type of amblyopia, and a reciprocal product of treatment efficacy, duration, and
compliance. Age at treatment onset is not predictive of outcome in many studies
but detection under versus over 2-3 years of age may be. Multiple screenings
prior to that age, and prompt treatment, reduce prevalence. Would a single early
cycloplegic photoscreening be as, or more, successful at detection or prediction
than the multiple screenings, and more cost-effective? Penalization and
occlusion have minimal incidence of reverse amblyopia and/or side-effects, no
significant influence on emmetropization, and no consistent effect on sign or
size of post-treatment changes in strabismic deviation. There may be a
physiologic basis for better age-indifferent outcome than tapped by current
treatment methodologies. Infant refractive correction substantially reduces
accommodative esotropia and amblyopia incidence without interference with
emmetropization. Compensatory prism, alone or post-operatively, and/or minus
lens treatment, and/or wide-field fusional amplitude training, may reduce risk
of early onset esotropia. Multivariate screening using continuous-scale
measurements may be more effective than traditional single-test dichotomous
pass/fail measures. Pigmentation may be one parameter because Caucasians are at
higher risk for esotropia than non-whites.
Acupuncture treatment
Arch Ophthalmol. 2010. Randomized controlled trial of patching vs
acupuncture for anisometropic amblyopia in children aged 7 to 12 years. Joint
Shantou International Eye Center of Shantou University and the Chinese
University of Hong Kong, China.
To compare the effectiveness of 2-hour daily patching with the effectiveness of
acupuncture in treating anisometropic amblyopia in children aged 7 to 12 years
who have worn optimal spectacles for at least 16 weeks. Acupuncture produced
equivalent treatment effect for anisometropic amblyopia, compared with patching,
and was statistically superior.
Emails
My son is 10 and he was diagnosed with amblyopia last year. The doctor told us
he has it in both eyes. He changed his prescription, (this was a new doctor),
and we went in for checkups. We started out at 20/50, with glasses, for close up
and far away. About 4 months ago his close up had improved to 20/30, with
glasses. The doctor kept his prescription the same without doing a diagnostic
check and we are to go to him for a another examination where he will then check
his eyes. We cannot patch his eyes to improve the condition because it is in
both eyes. I asked him about natural supplements and he said there weren't any.